Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Probiotics on Gut Microbiome in Healthy Subjects
NCT03756623Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of liquid metformin (Aspargo Labs), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Gut microbiota alterations at 12 weeks. Started Jun 2018; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
Beyond the preview
Go deeper on NCT03756623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756623.